{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:00:19Z","timestamp":1765609219663,"version":"3.48.0"},"reference-count":30,"publisher":"BMJ","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"published-print":{"date-parts":[[1994,4]]},"abstract":"<jats:p>Hepatitis C virus antibody titres (anti-HCV) were measured in serum from 122 patients with autoimmune liver disease (96 with primary biliary cirrhosis and 26 with autoimmune chronic active hepatitis using three generations of enzyme immunoassay (EIA): first generation--Ortho, EIA1; second generation--Abbott, EIA2; and third generation--Murex, EIA3. Anti-HCV was below the positive cut-off level in all 26 autoimmune chronic active hepatitis patients for all tests, while seropositivity values in primary biliary cirrhosis were 31% (EIA1), 14% (EIA2), and 0% (EIA3). In primary biliary cirrhosis, anti-HCV values as measured by all three tests correlated positively with serum IgG concentrations, serum storage time, and a number of other indices of hepatic dysfunction. Multiple regression analysis showed that anti-HCV values were independently affected by both serum IgG and the length of storage time, although the magnitude of the effects varied between tests. When all three multiple regression models were applied to an extreme clinical example, however, EIA3 was least likely to give a false-positive result. The difference in test performance was emphasised further by examination of anti-HCV values in nine primary biliary cirrhosis patients (confirmed negative by recombinant immunoblot assay 2) in whom serial samples were tested (seven to 14 per patient, stored for one to 138 months). Apparent anti-HCV values (EIA1 and EIA2) increased with increasing serum storage time, but were unchanged when measured by EIA3. A similar pattern was evident in a limited study of five autoimmune chronic active hepatitis patients. As the second generation EIA is in widespread use and confirmatory testing is not always available, the effect of serum storage in addition to hyperglobulinaemia should be considered in the interpretation of positive results in auto immune and in other types of chronic liver disease.<\/jats:p>","DOI":"10.1136\/gut.35.4.542","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T17:41:31Z","timestamp":1190137291000},"page":"542-546","source":"Crossref","is-referenced-by-count":12,"title":["Hepatitis C virus in autoimmune liver disease in the UK: aetiological agent or artefact?"],"prefix":"10.1136","volume":"35","author":[{"given":"B P","family":"Rowan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Gleeson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L P","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T W","family":"Warnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1994,4,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.2523562","article-title":"Isolation of a cDNA clone derived from a blood-borne Non-A, Non-B viral hepatitis genome","volume":"244","author":"Choo, Q.-L.; Kuo, G.; Weiner, A.J.; etal","year":"1989","unstructured":"Choo Q-L, Kuo G, Weiner AJ, etal. Isolation of a cDNA clone derived from a blood-borne Non-A, Non-B viral hepatitis genome. Science 1989; 244: 359-62.","journal-title":"Science"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1126\/science.2496467","article-title":"An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis","volume":"244","author":"Kuo, G.; Choo, Q.-L.; Alter, H.J.","year":"1989","unstructured":"Kuo G, Choo Q-L, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362-4.","journal-title":"Science"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0140-6736(90)91055-F","article-title":"Recombinant immunoblot assay for hepatitis C virus antibody as predictor of infectivity","volume":"335","author":"Ebeling, F.; Naukkarinen, R.; Leikola, J.","year":"1990","unstructured":"Ebeling F, Naukkarinen R, Leikola J. Recombinant immunoblot assay for hepatitis C virus antibody as predictor of infectivity. Lancet 1990; 335: 982-3.","journal-title":"Lancet"},{"key":"ref_4","first-page":"572","article-title":"Frequency and significance of antibody to hepatitis C virus in severe corticosteroid-treated autoimmune chronic active hepatitis","volume-title":"Mayo Clin Proc 1991","volume":"66","author":"Czaja, A.J.; Taswell, H.F.; Rakela, J.; Schimek, C.M.","unstructured":"Czaja AJ, Taswell HF, Rakela J, Schimek CM. Frequency and significance of antibody to hepatitis C virus in severe corticosteroid-treated autoimmune chronic active hepatitis. Mayo Clin Proc 1991; 66: 572-82."},{"key":"ref_5","first-page":"1009","article-title":"Hepatitis C virus antibodies in subjects with and without liver disease in the United Kingdom","volume":"282","author":"Jacyna, M.R.; O'Neill, K.; Brown, J.; Drobner, J.; Karayiannis, P.; Thomas, H.C.","year":"1990","unstructured":"Jacyna MR, O'Neill K, Brown J, Drobner J, Karayiannis P, Thomas HC. Hepatitis C virus antibodies in subjects with and without liver disease in the United Kingdom. Q J Med 1990; 282: 1009-12.","journal-title":"Q J Med"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/0140-6736(90)90870-B","article-title":"Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result?","volume":"335","author":"McFarlane, I.G.; Smith, H.M.; Johnson, P.J.","year":"1990","unstructured":"McFarlane IG, Smith HM, Johnson PJ, et al. Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result? Lancet 1990; 335: 754-7.","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3109\/00365529008998551","article-title":"Autoimmune chronic active hepatitis; changing reactivity for antibodies to hepatitis C virus after immunosuppressive treatment","volume":"25","year":"1990","unstructured":"Schvarcz R, Von Sydow M, Weiland 0. Autoimmune chronic active hepatitis; changing reactivity for antibodies to hepatitis C virus after immunosuppressive treatment. Scand J Gastroenterol 1990; 25: 1175-80.","journal-title":"Scand J Gastroenterol"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3109\/00365529008998550","article-title":"The significance of antihepatitis C virus antibodies measured in chronic liver disease","volume":"25","author":"true","year":"1990","unstructured":"Schrumpf E, Elgjo K, Fausa 0, et al. The significance of antihepatitis C virus antibodies measured in chronic liver disease. ScandJ Gastroenterol 1990; 25: 1169-74.","journal-title":"ScandJ Gastroenterol"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(89)90485-6","article-title":"Hepatitis C virus antibodies among risk groups in Spain","volume":"ii:","author":"Esteban, J.I.; Esteban, R.; Viladomiu, L.","year":"1989","unstructured":"Esteban JI, Esteban R, Viladomiu L, et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989; ii: 294-6.","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0168-8278(90)90231-F","article-title":"Prevalence of antibodies to hepatitis C in different aetiologies of cirrhosis","volume":"11","author":"Deny, P.; Nicolas, J.-C.; Loiseau, D.; Lefrere, J.-J.","year":"1990","unstructured":"Deny P, Nicolas J-C, Loiseau D, Lefrere J-J. Prevalence of antibodies to hepatitis C in different aetiologies of cirrhosis. J'Hepatol 1990; 11: 393.","journal-title":"J'Hepatol"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0140-6736(91)90418-O","article-title":"Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity","volume":"338","author":"Lenzi, M.; Johnson, P.J.; McFarlane, I.G.","year":"1991","unstructured":"Lenzi M, Johnson PJ, McFarlane IG, et al. Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. Lancet 1991; 338: 277-80.","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0168-8278(91)90874-B","article-title":"Hepatitis C virus-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM)","volume":"13","author":"Todros, L.; Touscoz, G.; U'Urso, N.","year":"1991","unstructured":"Todros L, Touscoz G, U'Urso N, et al. Hepatitis C virus-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM). J Hepatol 1991; 13: 128-31.","journal-title":"J Hepatol"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0168-8278(92)90037-P","article-title":"Hepatitis C virus testing in primary biliary cirrhosis","volume":"15","author":"Bertolini, E.; Battezzati, P.M.; Zermiani, P.","year":"1992","unstructured":"Bertolini E, Battezzati PM, Zermiani P, et al. Hepatitis C virus testing in primary biliary cirrhosis. J Hepatol 1992; 15: 207-10.","journal-title":"J Hepatol"},{"key":"ref_14","first-page":"626","article-title":"Anti-HCV in primary biliary cirrhosis","volume":"31","author":"Chiaramonte, M.; Floreani, A.; Giacomini, A.","year":"1990","unstructured":"Chiaramonte M, Floreani A, Giacomini A, et al. Anti-HCV in primary biliary cirrhosis. Gut 1990; 31: A626.","journal-title":"Gut"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/0140-6736(90)93297-3","article-title":"Anti-HCV testing in autoimmune hepatitis and primary biliary cirrhosis","volume":"336","author":"Fusconi, M.; Lenzi, M.; Ballardini, G.","year":"1990","unstructured":"Fusconi M, Lenzi M, Ballardini G, et al. Anti-HCV testing in autoimmune hepatitis and primary biliary cirrhosis. Lancet 1990; 336: 823.","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.7326\/0003-4819-114-3-252_1","article-title":"False-positive anti-HCV in biliary cirrhosis","volume":"114","author":"Housset, C.; Hirschauer, C.; Degos, F.","year":"1991","unstructured":"Housset C, Hirschauer C, Degos F. False-positive anti-HCV in biliary cirrhosis. Ann Intern Med 1991; 114: 252.","journal-title":"Ann Intern Med"},{"key":"ref_17","first-page":"56","article-title":"Is autoimmune chronic active hepatitis an HCV-related disease?","volume":"13","author":"Magrin, S.; Craxi, A.; Fiorentino, G.","year":"1991","unstructured":"Magrin S, Craxi A, Fiorentino G, et al. Is autoimmune chronic active hepatitis an HCV-related disease?J7 Hepatol 1991; 13: 56-60."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/0140-6736(90)91228-3","article-title":"Antibody to superoxide dismutase, autoimmune hepatitis and antibody tests for hepatitis C virus","volume":"335","author":"Ikeda, Y.; Toda, G.; Hasimoto, N.; Kurokawa, K.","year":"1990","unstructured":"Ikeda Y, Toda G, Hasimoto N, Kurokawa K. Antibody to superoxide dismutase, autoimmune hepatitis and antibody tests for hepatitis C virus. Lancet 1990; 335: 1345-6.","journal-title":"Lancet"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/0140-6736(90)91229-4","article-title":"False-positive antiHCV tests in rheumatoid arthritis","volume":"335","author":"Theilmann, L.; Blazek, M.; Goeser, T.","year":"1990","unstructured":"Theilmann L, Blazek M, Goeser T, et al. False-positive antiHCV tests in rheumatoid arthritis. Lancet 1990; 335: 1346.","journal-title":"Lancet"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0140-6736(90)91585-X","article-title":"False-positive hepatitis C virus antibody tests in paraproteinaemia","volume":"336","author":"Boudart, D.; Lucas, J.-C.; Muller, J.-Y.","year":"1990","unstructured":"Boudart D, Lucas J-C, Muller J-Y, et al. False-positive hepatitis C virus antibody tests in paraproteinaemia. Lancet 1990; 336: 63.","journal-title":"Lancet"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/jmv.1890320410","article-title":"Prevalence of Hepatitis C in South Africa: detection of anti-HCV in recent and stored serum","volume":"32","author":"Ellis, L.A.; Brown, D.; Conradie, J.D.","year":"1990","unstructured":"Ellis LA, Brown D, Conradie JD, et al. Prevalence of Hepatitis C in South Africa: detection of anti-HCV in recent and stored serum. J Med Virol 1990; 32: 249-51.","journal-title":"J Med Virol"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/hep.1840140503","article-title":"Overestimation of the prevalence of antibody to hepatitis C virus in retrospective studies on stored sera","volume":"14","author":"Lok, A.S.F.; Ma, O.C.K.; Chan, T.-M.","year":"1991","unstructured":"Lok ASF, Ma OCK, Chan T-M, et al. Overestimation of the prevalence of antibody to hepatitis C virus in retrospective studies on stored sera. Hepatology 1991; 14: 756-62.","journal-title":"Hepatology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0168-8278(05)80034-0","article-title":"Hepatitis C virus antibodies in acute and chronic liver disease in India","volume":"17","author":"Khuroo, M.S.; Dar, M.Y.; Zargar, S.A.","year":"1993","unstructured":"Khuroo MS, Dar MY, Zargar SA, et al. Hepatitis C virus antibodies in acute and chronic liver disease in India. J Hepatol 1993; 17: 175-9.","journal-title":"J Hepatol"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/hep.1840150105","article-title":"Improved detection of Hepatitis C virus antibodies in high-risk populations","volume":"15","author":"McHutchison, J.G.; Person, J.L.; Govindarajan, S.","year":"1992","unstructured":"McHutchison JG, Person JL, Govindarajan S, et al. Improved detection of Hepatitis C virus antibodies in high-risk populations. Hepatology 1992; 15: 19-25.","journal-title":"Hepatology"},{"key":"ref_25","first-page":"279","article-title":"Diagnosis of hepatitis C. Facts and perspectives","volume":"12","author":"Alberti, A.","year":"1991","unstructured":"Alberti A. Diagnosis of hepatitis C. Facts and perspectives. J3Hepatol 1991; 12: 279-82."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1136\/gut.33.9.1260","article-title":"Serum autoantibodies and the diagnosis of type-I autoimmune hepatitis in Italy: a reappraisal in the light of hepatitis C virus infection","volume":"33","author":"Cassani, F.; Muratori, L.; Manotti, P.","year":"1992","unstructured":"Cassani F, Muratori L, Manotti P, et al. Serum autoantibodies and the diagnosis of type-I autoimmune hepatitis in Italy: a reappraisal in the light of hepatitis C virus infection. Gut 1992; 33: 1260-3.","journal-title":"Gut"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/hep.1840160304","article-title":"Liver\/kidney microsome antibody type 1 and hepatitis C virus infection","volume":"16","author":"Lunel, F.; AbuafN, Frangeuil; L.","year":"1992","unstructured":"Lunel F, AbuafN, Frangeuil L, et al. Liver\/kidney microsome antibody type 1 and hepatitis C virus infection. Hepatology 1992; 16:630-6.","journal-title":"Hepatology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0140-6736(91)90942-I","article-title":"Confirmation of hepatitis C virus infection by new fourantigen recombinant immunoblot assay","volume":"337","author":"der Poel CL, Van; HTM, Cuypers; HW, Reesink","year":"1991","unstructured":"Van der Poel CL, Cuypers HTM, Reesink HW, et al. Confirmation of hepatitis C virus infection by new fourantigen recombinant immunoblot assay. Lancet 1991; 337: 317-9.","journal-title":"Lancet"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.7326\/0003-4819-116-1-51","article-title":"Autoimmune chronic active hepatitis exacerbated by alpha interferon","volume":"116","author":"Papo, T.; Marcellin, P.; Bernuau, J.","year":"1992","unstructured":"Papo T, Marcellin P, Bernuau J, et al. Autoimmune chronic active hepatitis exacerbated by alpha interferon. Ann Intern Med 1992; 116: 51-3.","journal-title":"Ann Intern Med"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/0016-5085(92)90786-X","article-title":"Acute exacerbation of liver disease during interferon alpha therapy for chronic hepatitis C","volume":"102","author":"Shindo, M.; DiBisceglie, A.M.; Hoofnagle, J.H.","year":"1992","unstructured":"Shindo M, DiBisceglie AM, Hoofnagle JH. Acute exacerbation of liver disease during interferon alpha therapy for chronic hepatitis C. Gastroenterology 1992; 102: 1406-8.","journal-title":"Gastroenterology"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gut.35.4.542","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T06:50:16Z","timestamp":1765608616000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gut.35.4.542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,4]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[1994,4,1]]},"published-print":{"date-parts":[[1994,4]]}},"alternative-id":["10.1136\/gut.35.4.542"],"URL":"https:\/\/doi.org\/10.1136\/gut.35.4.542","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"type":"print","value":"0017-5749"},{"type":"electronic","value":"1468-3288"}],"subject":[],"published":{"date-parts":[[1994,4]]}}}